These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8139735)
1. Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency. Chatelut E; Rostaing L; Gualano V; Vissac T; De Forni M; Ton-That H; Suc JM; Houin G; Canal P Nephron; 1994; 66(2):157-61. PubMed ID: 8139735 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer. Watanabe M; Aoki Y; Tomita M; Sato T; Takaki Y; Kato N; Kikuchi M; Kase H; Tanaka K Gynecol Oncol; 2002 Feb; 84(2):335-8. PubMed ID: 11812097 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis. Oguri T; Shimokata T; Inada M; Ito I; Ando Y; Sasaki Y; Hasegawa Y Cancer Chemother Pharmacol; 2010 Sep; 66(4):813-7. PubMed ID: 20563583 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of carboplatin in a patient under hemodialysis]. Kurata H; Yoshiya N; Ikarashi H; Kaneko T; Kodama S; Tanaka K; Suzuki K; Yoshizawa H; Cho T; Suzuki E Gan To Kagaku Ryoho; 1994 Mar; 21(4):547-50. PubMed ID: 8129398 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer. Yoshida H; Sumi T; Abe K; Ishiko O Eur J Gynaecol Oncol; 2009; 30(5):583-5. PubMed ID: 19899423 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis--case report. Yokoyama Y; Futagami M; Higuchi T; Mizunuma H Eur J Gynaecol Oncol; 2006; 27(4):437-9. PubMed ID: 17009648 [TBL] [Abstract][Full Text] [Related]
7. Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency. Motzer RJ; Niedzwiecki D; Isaacs M; Menendez-Botet C; Tong WP; Flombaum C; Scher HI; Bosl GJ Cancer Chemother Pharmacol; 1990; 27(3):234-8. PubMed ID: 2176133 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report]. Furuya Y; Takihana Y; Araki I; Tanabe N; Takeda M Gan To Kagaku Ryoho; 2003 Jul; 30(7):1017-20. PubMed ID: 12894722 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer. Hiraike M; Hiraki Y; Misumi N; Hanada K; Tsuji Y; Kamimura H; Karube Y; Kashiwabara K Cancer Chemother Pharmacol; 2012 Mar; 69(3):845-8. PubMed ID: 22194156 [TBL] [Abstract][Full Text] [Related]
11. [Safe and effective administration of carboplatin-based chemotherapy in a patient undergoing hemodialysis with cancer of unknown primary by monitoring observed AUC of carboplatin-a case report]. Kondo M; Kuroda J; Ikai Y; Hayashi R; Uegaki S; Yoshida T; Yoshida A; Komatsu H; Kimura K Gan To Kagaku Ryoho; 2012 Nov; 39(11):1749-52. PubMed ID: 23152033 [TBL] [Abstract][Full Text] [Related]
12. Carboplatin-based chemotherapy in patients undergoing hemodialysis. Yanagawa H; Takishita Y; Bando H; Sumitani H; Okada S Anticancer Res; 1996; 16(1):533-5. PubMed ID: 8615666 [TBL] [Abstract][Full Text] [Related]
13. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy]. Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma. Suzuki S; Koide M; Sakamoto S; Matsuo T Nephrol Dial Transplant; 1997 Jan; 12(1):137-40. PubMed ID: 9027788 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis. English MW; Lowis SP; Peng B; Boddy A; Newell DR; Price L; Pearson AD Br J Cancer; 1996 Mar; 73(6):776-80. PubMed ID: 8611379 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer. Adachi S; Ogasawara T; Ito K; Koyama M; Nagano T; Suzuki A; Yamada T; Nakata Y; Ozawa M Oncol Rep; 2001; 8(2):285-8. PubMed ID: 11182041 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature. Kamei K; Sako M; Ishikawa T; Sato M; Ogura M; Uno T; Kiyotani C; Mori T; Tanaka H; Ito S; Nakamura H Ther Apher Dial; 2015 Oct; 19(5):491-6. PubMed ID: 25916242 [TBL] [Abstract][Full Text] [Related]
19. Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma. Stiff PJ; McKenzie RS; Alberts DS; Sosman JA; Dolan JR; Rad N; McCloskey T J Clin Oncol; 1994 Jan; 12(1):176-83. PubMed ID: 8270975 [TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report]. Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]